Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Todd Matthew Morgan"'
Autor:
Anna Couvillon, Baris Turkbey, Peter L. Choyke, Katherine Lee-Wisdom, Yolanda McKinney, Robert Sidlow, Michael P. Mullane, Veda N. Giri, Todd Matthew Morgan, Heather H. Cheng, Maria J. Merino, William Douglas Figg, Peter A. Pinto, William L. Dahut, Fatima Karzai
Publikováno v:
Journal of Clinical Oncology. 41:390-390
390 Background: PCa has inherited risk factors including high genetic risk variants such as BRCA1/2, HOXB13, and DNA mismatch repair genes. mpMRI has been shown to be effective for detection and staging of localized PCa. This study follows participan
Autor:
Daniel Eidelberg Spratt, Vinnie YT Liu, Rikiya Yamashita, Emmalyn Chen, Sandy DeVries, Ashley Ross, Angela Jia, Todd Matthew Morgan, Seth A. Rosenthal, Howard M. Sandler, Osama Mohamad, Andre Esteva, Jedidiah Mercer Monson, Steven J. Chmura, John H Carson, Alan C Hartford, Albert J Chang, Stephanie L. Pugh, Phuoc T. Tran, Felix Y Feng
Publikováno v:
Journal of Clinical Oncology. 41:299-299
299 Background: Recently, an MMAI prognostic biomarker, ArteraAI Prostate, was trained and validated in localized prostate cancer to more accurately risk stratify patients for multiple endpoints compared to NCCN risk groups (Esteva et al., 2022). Pro
Autor:
Udit Singhal, Stephanie Daignault-Newton, Rodney Dunn, Daniel Eidelberg Spratt, Linda Okoth, Felix Y Feng, Anna Johnson, Brian R Lane, Susan Linsell, Ghani Khurshid, Rohit Mehra, Elai Davicioni, Thomas Maatman, Frank Burks, Paul Rodriguez, Eduardo Kleer, Richard Sarle, David Christopher Miller, Michael L. Cher, Todd Matthew Morgan
Publikováno v:
Journal of Clinical Oncology. 41:345-345
345 Background: Decipher is a tissue-based genomic classifier (GC) developed and validated in the post-radical prostatectomy (RP) setting to help guide adjuvant treatment decisions for prostate cancer (PCa). We conducted the first prospective, random
Autor:
Mack Roach, Jingbin Zhang, Andre Esteva, Osama Mohamad, Douwe Van der Wal, Jeffry Simko, Sandy DeVries, Huei-Chung Huang, Edward M. Schaeffer, Todd Matthew Morgan, Jedidiah Mercer Monson, Farah Naz, James Wallace, Michelle J. Ferguson, Jean-Paul Bahary, Howard M. Sandler, Daniel Eidelberg Spratt, Stephanie L. Pugh, Phuoc T. Tran, Felix Y Feng
Publikováno v:
Journal of Clinical Oncology. 40:108-108
108 Background: Artificial intelligence (AI) tools can display racial bias as a result of existing systemic health inequities and biased datasets. We have previously developed multi-modal AI (MMAI) prognostic models based on digital pathology images
Autor:
Andre Esteva, Jean Feng, Shih-Cheng Huang, Douwe Van der Wal, Jeffry Simko, Sandy DeVries, Emmalyn Chen, Edward M. Schaeffer, Todd Matthew Morgan, Jedidiah Mercer Monson, Farah Naz, James Wallace, Michelle J. Ferguson, Jean-Paul Bahary, Howard M. Sandler, Phuoc T. Tran, Daniel Eidelberg Spratt, Stephanie L. Pugh, Felix Y Feng, Osama Mohamad
Publikováno v:
Journal of Clinical Oncology. 40:222-222
222 Background: Prognostication in localized prostate cancer is reliant on non-specific tools, an issue that leads to the over- and under-treatment of patients. Various tissue-based molecular biomarkers have attempted to fill this unmet need, but mos
Autor:
Udit Singhal, Srinivas Nallandhighal, Jeffrey J. Tosoian, Trinh Pham, Chia-Jen Liu, Razeen Kareem, Komal Ramesh Kunder, Todd Matthew Morgan, Roberta Lucianò, Shahrokh F Shariat, Lucia Dambrosio, Claudio Doglioni, Scott A. Tomlins, Alberto Briganti, Ganesh S. Palapattu, Aaron M. Udager, Simpa Salami
Publikováno v:
Journal of Clinical Oncology. 40:266-266
266 Background: Primary prostate cancers (PCa) harbor multiple spatially distinct tumors with significant inter-lesion molecular heterogeneity. This diversity can result in many subclones that compete for biological and clinical dominance. The defini
Autor:
Mark Farha, Brittney Cotta, Randy Vince, Srinivas Nallandhighal, Samuel D. Kaffenberger, Philip Palmbos, Ajjai Shivaram Alva, Todd Matthew Morgan, Ganesh S. Palapattu, Simpa Salami, Aaron M. Udager
Publikováno v:
European Urology. 81:S1319
530 Background: Localized muscle-invasive bladder cancer (MIBC) exhibits heterogeneous molecular features and outcomes, with a 5-year mortality rate of approximately 30%. Immune checkpoint blockade (ICB) has the potential to improve oncological outco
Autor:
Edwin Melencio Posadas, Hiram Alberto Gay, Stephanie L. Pugh, Todd Matthew Morgan, James B. Yu, Stanislav Lechpammer, Felix Y Feng
Publikováno v:
Journal of Clinical Oncology. 38:TPS5601-TPS5601
TPS5601 Background: Salvage radiotherapy (SRT) is an important intervention for men with prostate cancer (PCa) who experience biochemical recurrence (BCR) after radical prostatectomy (RP). These patients are in need of cure or else they will develop